NSECertificate under SEBI (Depositories and Participants) Regulations, 20181d ago · 14 Oct 2026, 05:38 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sun Pharmaceutical Industries Limited · SUNPHARMA
✦ AI Summary
Sun Pharmaceutical Industries Limited has submitted a confirmation certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialisation during the quarter ended 30 September 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sun Pharmaceutical Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
SUNSEC_14102026173741_SEintimationfor74signed.pdf
View document text
Sun Pharmaceutical Industries Limited
SUN HOUSE, Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai 400063, India
Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343
Website: www.sunpharma.com
Email: secretarial@sunpharma.com
CIN: L24230GJ1993PLC019050
14 October 2026
National Stock Exchange of India Limited BSE Limited
Scrip Symbol: SUNPHARMA Scrip Code: 524715
Submission of Confirmation Certificate
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants)
Regulations, 2018, please find enclosed the certificate dated 03 October 2026 for the quarter ended 30
September 2026 received from M/s. MUFG Intime India Private Limited, Registrar & Share Transfer Agent
of the Company.
For Sun Pharmaceutical Industries Limited
(Anoop Deshpande)
Company Secretary and Compliance Officer
ICSI Membership No.: A23983
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA
Reaching People. Touching Lives
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 03-10-2026
The Compliance Officer/ Company Secretary
SUN PHARMACEUTICAL INDUSTRIES LIMITED
SPARC
AKOTA ROAD
AKOTA
VADODARA
PINCODE : 390020
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th September 2026, were confirmed (accepted/rejected) to the depositories by us and
that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are
listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services